TEKTURNA

This brand name is authorized in United States, South Africa

Active ingredients

The drug TEKTURNA contains one active pharmaceutical ingredient (API):

1 Aliskiren UNII C8A0P8G029 - ALISKIREN HEMIFUMARATE

Aliskiren is an orally active, non-peptide, potent and selective direct inhibitor of human renin. By inhibiting the enzyme renin, aliskiren inhibits the RAAS at the point of activation, blocking the conversion of angiotensinogen to angiotensin I and decreasing levels of angiotensin I and angiotensin II. Read about Aliskiren

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TEKTURNA Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09XA02	Aliskiren	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09X Other agents acting on the renin-angiotensin system → C09XA Renin-inhibitors
Discover more medicines within C09XA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 70839-150, 70839-300
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/7.1.3/0969, 41/7.1.3/0970